nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—Pruritus generalised—Octreotide—thymus cancer	0.0545	0.0545	CcSEcCtD
Buprenorphine—Appetite absent—Octreotide—thymus cancer	0.0366	0.0366	CcSEcCtD
Buprenorphine—Numbness—Octreotide—thymus cancer	0.022	0.022	CcSEcCtD
Buprenorphine—Sensory loss—Octreotide—thymus cancer	0.021	0.021	CcSEcCtD
Buprenorphine—Drug interaction—Octreotide—thymus cancer	0.0196	0.0196	CcSEcCtD
Buprenorphine—Injection site reaction—Octreotide—thymus cancer	0.0181	0.0181	CcSEcCtD
Buprenorphine—Wheezing—Octreotide—thymus cancer	0.0177	0.0177	CcSEcCtD
Buprenorphine—Influenza like illness—Octreotide—thymus cancer	0.0177	0.0177	CcSEcCtD
Buprenorphine—Sleep disorder—Octreotide—thymus cancer	0.0153	0.0153	CcSEcCtD
Buprenorphine—Injury—Octreotide—thymus cancer	0.0144	0.0144	CcSEcCtD
Buprenorphine—Hot flush—Octreotide—thymus cancer	0.0141	0.0141	CcSEcCtD
Buprenorphine—Menopausal symptoms—Octreotide—thymus cancer	0.014	0.014	CcSEcCtD
Buprenorphine—Visual disturbance—Octreotide—thymus cancer	0.0139	0.0139	CcSEcCtD
Buprenorphine—Osteoarthritis—Octreotide—thymus cancer	0.0132	0.0132	CcSEcCtD
Buprenorphine—Pain in extremity—Octreotide—thymus cancer	0.0132	0.0132	CcSEcCtD
Buprenorphine—Psychotic disorder—Octreotide—thymus cancer	0.0129	0.0129	CcSEcCtD
Buprenorphine—Dehydration—Octreotide—thymus cancer	0.0123	0.0123	CcSEcCtD
Buprenorphine—Dry skin—Octreotide—thymus cancer	0.0121	0.0121	CcSEcCtD
Buprenorphine—Abdominal pain upper—Octreotide—thymus cancer	0.0121	0.0121	CcSEcCtD
Buprenorphine—Cramp muscle—Octreotide—thymus cancer	0.0119	0.0119	CcSEcCtD
Buprenorphine—Nasopharyngitis—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Buprenorphine—Muscular weakness—Octreotide—thymus cancer	0.0116	0.0116	CcSEcCtD
Buprenorphine—Abdominal distension—Octreotide—thymus cancer	0.0115	0.0115	CcSEcCtD
Buprenorphine—Influenza—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Buprenorphine—Asthma—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Buprenorphine—Bronchospasm—Octreotide—thymus cancer	0.0112	0.0112	CcSEcCtD
Buprenorphine—Bronchitis—Octreotide—thymus cancer	0.011	0.011	CcSEcCtD
Buprenorphine—Abdominal discomfort—Octreotide—thymus cancer	0.0109	0.0109	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Buprenorphine—Weight decreased—Octreotide—thymus cancer	0.0103	0.0103	CcSEcCtD
Buprenorphine—Depression—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Buprenorphine—Conjunctivitis—Octreotide—thymus cancer	0.00989	0.00989	CcSEcCtD
Buprenorphine—Urinary tract infection—Octreotide—thymus cancer	0.00989	0.00989	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Octreotide—thymus cancer	0.00963	0.00963	CcSEcCtD
Buprenorphine—Sinusitis—Octreotide—thymus cancer	0.00955	0.00955	CcSEcCtD
Buprenorphine—Bradycardia—Octreotide—thymus cancer	0.0093	0.0093	CcSEcCtD
Buprenorphine—Rhinitis—Octreotide—thymus cancer	0.00916	0.00916	CcSEcCtD
Buprenorphine—Hypoaesthesia—Octreotide—thymus cancer	0.00909	0.00909	CcSEcCtD
Buprenorphine—Pharyngitis—Octreotide—thymus cancer	0.00907	0.00907	CcSEcCtD
Buprenorphine—Oedema peripheral—Octreotide—thymus cancer	0.009	0.009	CcSEcCtD
Buprenorphine—Visual impairment—Octreotide—thymus cancer	0.00881	0.00881	CcSEcCtD
Buprenorphine—Tinnitus—Octreotide—thymus cancer	0.00852	0.00852	CcSEcCtD
Buprenorphine—Flushing—Octreotide—thymus cancer	0.00848	0.00848	CcSEcCtD
Buprenorphine—Cardiac disorder—Octreotide—thymus cancer	0.00848	0.00848	CcSEcCtD
Buprenorphine—Immune system disorder—Octreotide—thymus cancer	0.00825	0.00825	CcSEcCtD
Buprenorphine—Mental disorder—Octreotide—thymus cancer	0.00801	0.00801	CcSEcCtD
Buprenorphine—Erythema—Octreotide—thymus cancer	0.00795	0.00795	CcSEcCtD
Buprenorphine—Malnutrition—Octreotide—thymus cancer	0.00795	0.00795	CcSEcCtD
Buprenorphine—Flatulence—Octreotide—thymus cancer	0.00784	0.00784	CcSEcCtD
Buprenorphine—Tension—Octreotide—thymus cancer	0.00781	0.00781	CcSEcCtD
Buprenorphine—Nervousness—Octreotide—thymus cancer	0.00773	0.00773	CcSEcCtD
Buprenorphine—Back pain—Octreotide—thymus cancer	0.00769	0.00769	CcSEcCtD
Buprenorphine—Muscle spasms—Octreotide—thymus cancer	0.00765	0.00765	CcSEcCtD
Buprenorphine—Vision blurred—Octreotide—thymus cancer	0.0075	0.0075	CcSEcCtD
Buprenorphine—Tremor—Octreotide—thymus cancer	0.00745	0.00745	CcSEcCtD
Buprenorphine—Ill-defined disorder—Octreotide—thymus cancer	0.00738	0.00738	CcSEcCtD
Buprenorphine—Agitation—Octreotide—thymus cancer	0.00731	0.00731	CcSEcCtD
Buprenorphine—Malaise—Octreotide—thymus cancer	0.00717	0.00717	CcSEcCtD
Buprenorphine—Vertigo—Octreotide—thymus cancer	0.00715	0.00715	CcSEcCtD
Buprenorphine—Syncope—Octreotide—thymus cancer	0.00713	0.00713	CcSEcCtD
Buprenorphine—Palpitations—Octreotide—thymus cancer	0.00703	0.00703	CcSEcCtD
Buprenorphine—Loss of consciousness—Octreotide—thymus cancer	0.00699	0.00699	CcSEcCtD
Buprenorphine—Cough—Octreotide—thymus cancer	0.00694	0.00694	CcSEcCtD
Buprenorphine—Convulsion—Octreotide—thymus cancer	0.00689	0.00689	CcSEcCtD
Buprenorphine—Hypertension—Octreotide—thymus cancer	0.00687	0.00687	CcSEcCtD
Buprenorphine—Chest pain—Octreotide—thymus cancer	0.00677	0.00677	CcSEcCtD
Buprenorphine—Myalgia—Octreotide—thymus cancer	0.00677	0.00677	CcSEcCtD
Buprenorphine—Arthralgia—Octreotide—thymus cancer	0.00677	0.00677	CcSEcCtD
Buprenorphine—Anxiety—Octreotide—thymus cancer	0.00675	0.00675	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00673	0.00673	CcSEcCtD
Buprenorphine—Discomfort—Octreotide—thymus cancer	0.00669	0.00669	CcSEcCtD
Buprenorphine—Dry mouth—Octreotide—thymus cancer	0.00662	0.00662	CcSEcCtD
Buprenorphine—Anaphylactic shock—Octreotide—thymus cancer	0.00649	0.00649	CcSEcCtD
Buprenorphine—Oedema—Octreotide—thymus cancer	0.00649	0.00649	CcSEcCtD
Buprenorphine—Infection—Octreotide—thymus cancer	0.00645	0.00645	CcSEcCtD
Buprenorphine—Shock—Octreotide—thymus cancer	0.00639	0.00639	CcSEcCtD
Buprenorphine—Nervous system disorder—Octreotide—thymus cancer	0.00637	0.00637	CcSEcCtD
Buprenorphine—Tachycardia—Octreotide—thymus cancer	0.00634	0.00634	CcSEcCtD
Buprenorphine—Skin disorder—Octreotide—thymus cancer	0.00631	0.00631	CcSEcCtD
Buprenorphine—Hyperhidrosis—Octreotide—thymus cancer	0.00628	0.00628	CcSEcCtD
Buprenorphine—Anorexia—Octreotide—thymus cancer	0.00619	0.00619	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00591	0.00591	CcSEcCtD
Buprenorphine—Insomnia—Octreotide—thymus cancer	0.00587	0.00587	CcSEcCtD
Buprenorphine—Paraesthesia—Octreotide—thymus cancer	0.00583	0.00583	CcSEcCtD
Buprenorphine—Dyspnoea—Octreotide—thymus cancer	0.00579	0.00579	CcSEcCtD
Buprenorphine—Somnolence—Octreotide—thymus cancer	0.00577	0.00577	CcSEcCtD
Buprenorphine—Dyspepsia—Octreotide—thymus cancer	0.00571	0.00571	CcSEcCtD
Buprenorphine—Decreased appetite—Octreotide—thymus cancer	0.00564	0.00564	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Octreotide—thymus cancer	0.0056	0.0056	CcSEcCtD
Buprenorphine—Fatigue—Octreotide—thymus cancer	0.0056	0.0056	CcSEcCtD
Buprenorphine—Constipation—Octreotide—thymus cancer	0.00555	0.00555	CcSEcCtD
Buprenorphine—Pain—Octreotide—thymus cancer	0.00555	0.00555	CcSEcCtD
Buprenorphine—Feeling abnormal—Octreotide—thymus cancer	0.00535	0.00535	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Octreotide—thymus cancer	0.00531	0.00531	CcSEcCtD
Buprenorphine—Urticaria—Octreotide—thymus cancer	0.00516	0.00516	CcSEcCtD
Buprenorphine—Abdominal pain—Octreotide—thymus cancer	0.00513	0.00513	CcSEcCtD
Buprenorphine—Body temperature increased—Octreotide—thymus cancer	0.00513	0.00513	CcSEcCtD
Buprenorphine—Hypersensitivity—Octreotide—thymus cancer	0.00478	0.00478	CcSEcCtD
Buprenorphine—Asthenia—Octreotide—thymus cancer	0.00466	0.00466	CcSEcCtD
Buprenorphine—Pruritus—Octreotide—thymus cancer	0.00459	0.00459	CcSEcCtD
Buprenorphine—Diarrhoea—Octreotide—thymus cancer	0.00444	0.00444	CcSEcCtD
Buprenorphine—Dizziness—Octreotide—thymus cancer	0.00429	0.00429	CcSEcCtD
Buprenorphine—Vomiting—Octreotide—thymus cancer	0.00413	0.00413	CcSEcCtD
Buprenorphine—Rash—Octreotide—thymus cancer	0.00409	0.00409	CcSEcCtD
Buprenorphine—Dermatitis—Octreotide—thymus cancer	0.00409	0.00409	CcSEcCtD
Buprenorphine—Headache—Octreotide—thymus cancer	0.00407	0.00407	CcSEcCtD
Buprenorphine—Nausea—Octreotide—thymus cancer	0.00386	0.00386	CcSEcCtD
